Company Filing History:
Years Active: 2011-2024
Title: The Innovative Contributions of Mike Stratton
Introduction
Mike Stratton, an accomplished inventor based in Hinxton, GB, has made significant strides in the field of genetic research. With three patents to his name, Stratton is recognized for his innovative approaches to detecting mutations that play a critical role in cancer diagnosis and treatment.
Latest Patents
Stratton's latest patents reflect his expertise in genomics. One of these patents is a method of detecting a mutational signature in a DNA sample. This invention provides a detailed process for identifying mutations arising from rearrangements in the DNA and analyzing their contributions. The method involves computing cosine similarity between rearrangement mutations and mutational signatures, classifying these findings based on their nature, such as clustered or non-clustered, tandem duplications, deletions, inversions, or translocations.
Another notable patent that Stratton holds addresses the detection of the oncogenic T1796A B-Raf mutation. This invention focuses on mutations in B-Raf gene products, which are found in human tumors of natural origin. These mutations are crucial as they are associated with cancerous phenotypes, providing a foundation for the diagnosis of cancer and potential development of anti-cancer therapeutics.
Career Highlights
Throughout his career, Stratton has been affiliated with prestigious organizations, including The Wellcome Trust Limited and Genome Research Limited. His work in these institutions has greatly influenced the landscape of cancer research and treatment options available today.
Collaborations
Stratton has collaborated with esteemed colleagues such as Andy Futreal and Richard Wooster, further enhancing his contributions to the world of genetic research. These collaborative efforts have paved the way for groundbreaking advancements in the understanding and diagnosis of genetic mutations.
Conclusion
Mike Stratton's innovations in the field of genetics not only demonstrate his commitment to scientific progress but also highlight the importance of research in understanding complex diseases like cancer. His patents are a testament to the ongoing efforts to improve diagnostics and therapeutic strategies, ultimately benefiting countless individuals facing health challenges.